Walter E. Aulitzky

1.1k total citations
8 papers, 173 citations indexed

About

Walter E. Aulitzky is a scholar working on Molecular Biology, Oncology and Complementary and alternative medicine. According to data from OpenAlex, Walter E. Aulitzky has authored 8 papers receiving a total of 173 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Complementary and alternative medicine. Recurrent topics in Walter E. Aulitzky's work include Toxin Mechanisms and Immunotoxins (2 papers), vaccines and immunoinformatics approaches (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). Walter E. Aulitzky is often cited by papers focused on Toxin Mechanisms and Immunotoxins (2 papers), vaccines and immunoinformatics approaches (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). Walter E. Aulitzky collaborates with scholars based in Germany, Switzerland and Austria. Walter E. Aulitzky's co-authors include RA Bowden, Guenther Gastl, C. Huber, Magdolna Herold, Bernhard Meister, W. Woloszczuk, H. Toomes, Annika Nelde, Tatjana Bilich and Raimund Margreiter and has published in prestigious journals such as Journal of Clinical Oncology, Frontiers in Immunology and Transplantation.

In The Last Decade

Walter E. Aulitzky

7 papers receiving 170 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Walter E. Aulitzky Germany	6	111	78	47	38	29	8	173
Jordi Milá Spain	11	113 1.0×	27 0.3×	56 1.2×	43 1.1×	39 1.3×	17	244
Lu‐En Wai Singapore	6	111 1.0×	19 0.2×	37 0.8×	75 2.0×	22 0.8×	13	190
Melody Cheong Australia	5	219 2.0×	173 2.2×	24 0.5×	35 0.9×	7 0.2×	6	270
June Takeda Japan	6	110 1.0×	120 1.5×	32 0.7×	23 0.6×	18 0.6×	19	215
Kane Kaosaard United States	6	258 2.3×	156 2.0×	55 1.2×	75 2.0×	9 0.3×	8	317
Luke Samson Australia	6	137 1.2×	113 1.4×	39 0.8×	111 2.9×	13 0.4×	10	208
Lukas M. Braun Germany	9	43 0.4×	67 0.9×	63 1.3×	53 1.4×	10 0.3×	11	172
Sarah Thirkell United Kingdom	3	215 1.9×	15 0.2×	32 0.7×	99 2.6×	39 1.3×	8	283
Georg Wittkowsky Germany	4	105 0.9×	385 4.9×	163 3.5×	127 3.3×	10 0.3×	4	400
Lucy W. Kappel United States	5	243 2.2×	186 2.4×	48 1.0×	27 0.7×	7 0.2×	6	303

Countries citing papers authored by Walter E. Aulitzky

Since Specialization

Citations

This map shows the geographic impact of Walter E. Aulitzky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter E. Aulitzky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter E. Aulitzky more than expected).

Fields of papers citing papers by Walter E. Aulitzky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walter E. Aulitzky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter E. Aulitzky. The network helps show where Walter E. Aulitzky may publish in the future.

Co-authorship network of co-authors of Walter E. Aulitzky

This figure shows the co-authorship network connecting the top 25 collaborators of Walter E. Aulitzky. A scholar is included among the top collaborators of Walter E. Aulitzky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walter E. Aulitzky. Walter E. Aulitzky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Nelde, Annika, Yacine Maringer, Tatjana Bilich, et al.. (2021). Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic Leukemia. Frontiers in Immunology. 12. 705974–705974. 23 indexed citations

2.

Tresckow, Bastian von, Dennis A. Eichenauer, Walter E. Aulitzky, et al.. (2014). First-in-human study of 4SC-202, a novel oral HDAC inhibitor in advanced hematologic malignancies (TOPAS study).. Journal of Clinical Oncology. 32(15_suppl). 8559–8559. 8 indexed citations

3.

Richly, Heike, Luise Maute, Gerhard Heil, et al.. (2013). Prospective randomized phase II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: A study of the CESAR Central European Society for Anticancer Drug Research-EWIV.. Journal of Clinical Oncology. 31(15_suppl). 4035–4035. 7 indexed citations

4.

Voelter, Wolfgang, Thomas E. Mürdter, Isabel Siegle, Péter Fritz, & Walter E. Aulitzky. (2001). Therapie mit Mistelextrakten in der Onkologie. Der Onkologe. 7(11). 1247–1252.

5.

Fritz, Péter, Thomas E. Mürdter, Isabel Siegle, Walter E. Aulitzky, & Wolfgang Voelter. (2001). Therapie mit Mistelextrakten in der Onkologie. Der Urologe B. 41(5). 466–471. 1 indexed citations

6.

Fritz, Péter, Thomas E. Mürdter, Heyo K. Kroemer, et al.. (1999). Ligands for Viscum album agglutinin and galectin-1 in human lung cancer: Is there any prognostic relevance?. Acta Histochemica. 101(3). 239–253. 15 indexed citations

7.

Herold, Magdolna, W. Woloszczuk, Walter E. Aulitzky, et al.. (1990). ENDOGENOUS IFN-GAMMA DURING HUMAN BONE MARROW TRANSPLANTATION. Transplantation. 50(4). 620–624. 98 indexed citations

8.

Vogel, Wolfgang, Johann Koller, M Spielberger, et al.. (1988). PRELIMINARY RESULTS WITH COMBINED HEPATORENAL ALLOGRAFTING. Transplantation. 45(2). 491–492. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact